Natera, Inc.·4

Mar 3, 9:05 PM ET

Sheena Jonathan 4

4 · Natera, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Sheena Jonathan
DirectorOther
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-02-27+2,103265,264 total
  • Sale

    Common Stock

    [F3][F4]
    2026-03-02$198.50/sh470$93,293264,794 total
  • Sale

    Common Stock

    [F3][F5]
    2026-03-02$200.42/sh2,400$481,012262,394 total
  • Sale

    Common Stock

    [F3]
    2026-03-02$201.20/sh100$20,120262,294 total
  • Sale

    Common Stock

    [F3]
    2026-03-02$202.85/sh100$20,285262,194 total
Holdings
  • Common Stock

    [F6]
    (indirect: By Trust)
    21,782
  • Common Stock

    [F6]
    (indirect: By Trust)
    21,782
Footnotes (6)
  • [F1]Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.24 to $198.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.7950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    form4-03032026_090305.xmlPrimary